An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors

Clinical trial NCT07293754 · RECRUITING

Trial details

NCT number: NCT07293754
Sponsor: Repertoire Immune Medicines
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor

Start date: 2025-12-12
Primary completion: 2028-12-15
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.